Orion Oyj Series A | Ownership
Companies that own Orion Oyj Series A
Keskinäinen Eläkevakuutusyhtiö Ilmarinen
3,008,794
8.11%
1,034,099
0.64%
12/31/2017
Dimensional Fund Advisors LP
201,759
0.54%
2,260
0%
09/06/2018
Nordea Investment Management AB (Denmark)
80,173
0.22%
11,822
0%
05/31/2018
Sector Omega AS
36,700
0.1%
36,700
0.62%
12/31/2016
TD Asset Management, Inc.
28,186
0.08%
-51
0%
12/31/2017
RAM Active Investments SA
9,926
0.03%
9,926
0.01%
06/30/2017
Dimensional Fund Advisors Ltd.
8,554
0.02%
2,355
0%
11/30/2017
Russell Investments Ltd.
7,971
0.02%
-1,611
0%
09/30/2017
Bessemer Investment Management LLC
6,792
0.02%
0
0%
04/30/2018
JPMorgan Investment Management, Inc.
4,658
0.01%
0
0%
09/06/2018
| Address |
Orionintie 1A
Espoo UU 02200
Finland
|
|
Employees
|
- |
| Website |
http://www.orion.fi |
| Updated |
07/08/2019 |
| Orion Oyj engages in the development of pharmaceutical and diagnostic test. It develops, manufactures, and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. Its pharmaceutical research and development focuses on central nervous system drugs, oncology and critical care drugs, and Easyhaler pulmonary drugs. |
